AstraZeneca United States
Time frame: 1 February 2023 - 31 January 2024Article ‘Count’ and ‘Share’ for AstraZeneca United States based on listed parameters only.
The articles listed below published by authors from AstraZeneca United States, organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
American Journal of Respiratory and Critical Care Medicine |
2 | 0.39 |
Blood |
1 | 0.17 |
Chest |
2 | 0.36 |
Circulation |
1 | 0.08 |
Clinical Infectious Diseases |
1 | 0.08 |
Diabetes Care |
1 | 0.13 |
European Heart Journal |
2 | 0.23 |
JAMA: The Journal of the American Medical Association |
1 | 0.03 |
Journal of Clinical Oncology |
5 | 0.45 |
Journal of Infectious Diseases |
1 | 0.73 |
Journal of the American Society of Nephrology |
1 | 0.15 |
Nature |
1 | 0.01 |
Nature Communications |
9 | 1.67 |
Nature Medicine |
1 | 0.82 |
Science |
1 | 0.01 |
Science Advances |
1 | 0.05 |
The Lancet Oncology |
1 | 0.07 |
The New England Journal of Medicine |
1 | 0.04 |
Thorax |
1 | 0.13 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.